BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
caplin point lab ltd. stock

CAPLIN POINT LAB LTD. Share Price

2446.55 8.10 (0.33%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: CAPLIPOINT

CAPLIN POINT LAB LTD. Share Price Update

As of the latest trading session, CAPLIN POINT LAB LTD. share price is currently at 2446.55, which is up by 8.10 from its previous closing. Today, the stock has fluctuated between 2363.90 and 2458.45. Over the past year, CAPLIN POINT LAB LTD. has achieved a return of 100.32 %. In the last month alone, the return has been 25.20 %. Read More...

CAPLIN POINT LAB LTD. Performance

Day Range

Low2363.90 High2458.45
2446.55

52 Week Range

Low 1178.00 High 2490.00
2446.55

CAPLIN POINT LAB LTD. Share Price

3906

524742

CAPLIPOINT

img img img img
No Data Available

Open Price

2438.90

Prev. Close

2438.45

Volume (Shares)

98942.00

Total traded value

2420.66

Upper Circuit

2926.10

Lower Circuit

1950.80

Note: The current prices & values are delayed, Login to your account for live updates.

CAPLIN POINT LAB LTD. Fundamentals


(Standalone)

Market Cap (Cr) 18579.53
PE Ratio (TTM) 61.24
Book Value / Share 201.93
Beta 0.75
ROE 22.43%
EPS (TTM) 39.94
Dividend Yield 0.20%
Net Profit Qtr (Cr) 105.74

CAPLIN POINT LAB LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 207.93
Operating Expense 116.28
Net Profit 105.74
Net Profit Margin (%) 50.85
Earnings Per Share (EPS) 13.92
EBITDA 141.17
Effective Tax Rate (%) 21.47
Particulars JUN 2024 (Values in Cr)
Revenue 185.64
Operating Expense 110.46
Net Profit 72.54
Net Profit Margin (%) 39.07
Earnings Per Share (EPS) 9.55
EBITDA 102.88
Effective Tax Rate (%) 24.96
Particulars MAR 2024 (Values in Cr)
Revenue 139.38
Operating Expense 88.64
Net Profit 69.88
Net Profit Margin (%) 50.13
Earnings Per Share (EPS) 9.20
EBITDA 93.85
Effective Tax Rate (%) 19.59
Particulars DEC 2023 (Values in Cr)
Revenue 132.83
Operating Expense 76.30
Net Profit 55.45
Net Profit Margin (%) 41.74
Earnings Per Share (EPS) 7.30
EBITDA 81.22
Effective Tax Rate (%) 25.50
Particulars SEP 2023 (Values in Cr)
Revenue 179.22
Operating Expense 96.50
Net Profit 82.10
Net Profit Margin (%) 45.80
Earnings Per Share (EPS) 10.82
EBITDA 113.94
Effective Tax Rate (%) 23.41
Particulars MAR 2024 (Values in Cr)
Revenue 625.09
Operating Expense 365.19
Net Profit 283.71
Net Profit Margin (%) 45.38
Earnings Per Share (EPS) 37.36
EBITDA 392.92
Effective Tax Rate (%) 22.42
Particulars MAR 2023 (Values in Cr)
Revenue 528.61
Operating Expense 334.46
Net Profit 234.26
Net Profit Margin (%) 44.31
Earnings Per Share (EPS) 30.89
EBITDA 318.91
Effective Tax Rate (%) 20.08
Particulars MAR 2022 (Values in Cr)
Revenue 528.06
Operating Expense 334.29
Net Profit 187.87
Net Profit Margin (%) 35.57
Earnings Per Share (EPS) 24.82
EBITDA 276.17
Effective Tax Rate (%) 24.94
Particulars MAR 2021 (Values in Cr)
Revenue 482.68
Operating Expense 291.36
Net Profit 156.23
Net Profit Margin (%) 32.36
Earnings Per Share (EPS) 20.65
EBITDA 232.54
Effective Tax Rate (%) 25.58
Particulars MAR 2020 (Values in Cr)
Revenue 527.83
Operating Expense 340.66
Net Profit 197.65
Net Profit Margin (%) 37.44
Earnings Per Share (EPS) 26.13
EBITDA 272.96
Effective Tax Rate (%) 21.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 276.38
ROE % 24.52
ROCE % 26.67
Total Debt to Total Equity 0.00
EBITDA Margin 36.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 219.22
ROE % 25.72
ROCE % 26.56
Total Debt to Total Equity 0.00
EBITDA Margin 33.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 167.20
ROE % 27.58
ROCE % 28.38
Total Debt to Total Equity 0.01
EBITDA Margin 34.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 128.12
ROE % 27.29
ROCE % 28.40
Total Debt to Total Equity 0.03
EBITDA Margin 33.18
Particulars MAR 2020 (Values in Cr)
Book Value / Share 96.68
ROE % 29.26
ROCE % 32.92
Total Debt to Total Equity 0.02
EBITDA Margin 34.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 183.03
ROE % 22.43
ROCE % 28.84
Total Debt to Total Equity 0.00
EBITDA Margin 62.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 150.19
ROE % 22.63
ROCE % 28.24
Total Debt to Total Equity 0.00
EBITDA Margin 60.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 122.78
ROE % 22.24
ROCE % 29.50
Total Debt to Total Equity 0.00
EBITDA Margin 52.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.29
ROE % 23.00
ROCE % 30.68
Total Debt to Total Equity 0.00
EBITDA Margin 48.18
Particulars MAR 2020 (Values in Cr)
Book Value / Share 79.31
ROE % 38.30
ROCE % 48.69
Total Debt to Total Equity 0.00
EBITDA Margin 51.72
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 552.74
Total Assets 2698.12
Total Liabilities 2698.12
Total Equity 2346.83
Share Outstanding 75941746
Price to Book Ratio 7.20
Return on Assets (%) 16.94
Return on Capital (%) 19.47
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 493.48
Total Assets 2191.40
Total Liabilities 2191.40
Total Equity 1907.27
Share Outstanding 75902746
Price to Book Ratio 3.97
Return on Assets (%) 17.16
Return on Capital (%) 19.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 462.99
Total Assets 1736.32
Total Liabilities 1736.32
Total Equity 1509.88
Share Outstanding 75788876
Price to Book Ratio 5.54
Return on Assets (%) 17.26
Return on Capital (%) 19.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 438.33
Total Assets 1363.61
Total Liabilities 1363.61
Total Equity 1203.37
Share Outstanding 75642750
Price to Book Ratio 4.03
Return on Assets (%) 17.76
Return on Capital (%) 19.85
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 223.42
Total Assets 1125.75
Total Liabilities 1125.75
Total Equity 956.57
Share Outstanding 75642750
Price to Book Ratio 3.56
Return on Assets (%) 19.09
Return on Capital (%) 22.48
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 215.78
Total Assets 1522.31
Total Liabilities 1522.31
Total Equity 1390.15
Share Outstanding 75941746
Price to Book Ratio 7.20
Return on Assets (%) 18.63
Return on Capital (%) 20.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 271.38
Total Assets 1303.18
Total Liabilities 1303.18
Total Equity 1139.91
Share Outstanding 75902746
Price to Book Ratio 3.97
Return on Assets (%) 17.97
Return on Capital (%) 20.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 316.08
Total Assets 1054.16
Total Liabilities 1054.16
Total Equity 930.65
Share Outstanding 75788876
Price to Book Ratio 5.54
Return on Assets (%) 17.82
Return on Capital (%) 20.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 345.49
Total Assets 860.99
Total Liabilities 860.99
Total Equity 758.67
Share Outstanding 75642750
Price to Book Ratio 4.03
Return on Assets (%) 18.14
Return on Capital (%) 20.59
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 58.26
Total Assets 691.32
Total Liabilities 691.32
Total Equity 599.90
Share Outstanding 75642750
Price to Book Ratio 3.56
Return on Assets (%) 28.58
Return on Capital (%) 32.94
Particulars MAR 2024 (Values in Cr)
Net Income 564.43
Cash from Operations 427.39
Cash from Investing -320.04
Cash from Financing -38.07
Net change in Cash -39.72
Free Cash Flow 573.21
Particulars MAR 2023 (Values in Cr)
Net Income 451.35
Cash from Operations 359.37
Cash from Investing -217.58
Cash from Financing -28.17
Net change in Cash 25.62
Free Cash Flow 552.84
Particulars MAR 2022 (Values in Cr)
Net Income 385.82
Cash from Operations 418.23
Cash from Investing -376.77
Cash from Financing -40.68
Net change in Cash -80.72
Free Cash Flow 509.41
Particulars MAR 2021 (Values in Cr)
Net Income 313.62
Cash from Operations 334.75
Cash from Investing -29.44
Cash from Financing -23.98
Net change in Cash 215.19
Free Cash Flow 408.08
Particulars MAR 2020 (Values in Cr)
Net Income 269.46
Cash from Operations 99.44
Cash from Investing -54.50
Cash from Financing 79.76
Net change in Cash 69.93
Free Cash Flow 176.17
Particulars MAR 2024 (Values in Cr)
Net Income 365.74
Cash from Operations 198.10
Cash from Investing -118.94
Cash from Financing -34.26
Net change in Cash -42.19
Free Cash Flow 221.17
Particulars MAR 2023 (Values in Cr)
Net Income 293.15
Cash from Operations 222.14
Cash from Investing -86.67
Cash from Financing -30.42
Net change in Cash 40.01
Free Cash Flow 280.77
Particulars MAR 2022 (Values in Cr)
Net Income 250.31
Cash from Operations 292.95
Cash from Investing -275.93
Cash from Financing -22.76
Net change in Cash -67.72
Free Cash Flow 300.17
Particulars MAR 2021 (Values in Cr)
Net Income 209.94
Cash from Operations 349.54
Cash from Investing -3.71
Cash from Financing -3.47
Net change in Cash 287.46
Free Cash Flow 392.09
Particulars MAR 2020 (Values in Cr)
Net Income 253.12
Cash from Operations 137.35
Cash from Investing -41.05
Cash from Financing -32.91
Net change in Cash 13.03
Free Cash Flow 186.54
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2425.60
  • 26 Days 2225.30
  • 10 Days 2378.70
  • 50 Days 2130.70
  • 12 Days 2346.40
  • 100 Days 1948.10
  • 20 Days 2253.50
  • 200 Days 1546.30
2445.42
PIVOT
First Resistance 2462.83
Second Resistance 2487.22
Third Resistance 2504.63
First Support 2421.03
Second Support 2403.62
Third Support 2379.23
RSI 73.66
MACD 121.10
Commodity Channel Index (CCI) 85.53
ADX 53.87
Williams % R -8.48

Over 1 Month

down

25.20

Over 3 Months

down

26.80

Over 6 Months

down

74.99

Over 1 Year

down

100.32

Over 3 Years

down

45.39

Over 5 Years

down

51.49

CAPLIN POINT LAB LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

CAPLIN POINT LAB LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
23.9
Promoter Holdings
70.55
FII
3.7
DII
1.83
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
P Vijayalakshmi Shareholding of Promoter and Promoter Group 1.877879E7 24.71
Paarthipan C C Shareholding of Promoter and Promoter Group 1.4167192E7 18.64
Ashok Gorkey Partheeban Shareholding of Promoter and Promoter Group 9050000.0 11.91
Partheeban Vivek Siddarth Shareholding of Promoter and Promoter Group 9000000.0 11.84
May India Property Private Limited Shareholding of Promoter and Promoter Group 2117000.0 2.79
Uti Small Cap Fund Public Shareholding 1114352.0 1.47
First Dimension Holdings Private Limited Shareholding of Promoter and Promoter Group 370000.0 0.49
Kiraviz Properties And Consultancy Llp Shareholding of Promoter and Promoter Group 150000.0 0.2

CAPLIN POINT LAB LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-14 2.5 Final 2023-09-14 Equity shares 2023-06-09 2.0 Interim 2023-06-09 Equity shares 2022-09-21 2.0 Final 2022-09-22 Equity shares 2022-05-23 2.0 Interim 2022-05-24 Equity shares 2021-09-20 1.5 Final 2021-09-21 Equity shares 2021-05-18 1.5 Interim 2021-05-19 Equity shares 2020-09-21 0.4 Final 2020-09-23 Equity shares 2020-03-12 2.1 Interim 2020-03-13 Equity shares 2019-09-04 2.2 Final 2019-09-06 Equity shares 2018-09-18 2.0 Final 2018-09-20 Equity shares 2017-09-07 1.5 Final 2017-09-09 Equity shares 2016-09-01 3.5 Final 2016-09-03 Equity shares 2016-02-15 2.5 Interim 2016-02-16 Equity shares 2015-10-29 5.0 Final 2015-10-31 Equity shares 2014-12-11 4.0 Final 2014-12-13 Equity shares 2013-12-19 2.5 Final 2013-12-21 Equity shares 2012-12-11 2.0 Final 2012-12-13 Equity shares 2011-12-12 1.5 Final 2011-12-24 Equity shares 2010-12-09 1.0 Final 2010-12-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2016-10-19 10.0 2.0 2016-10-20

Learn More About Stocks

About CAPLIN POINT LAB LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by CAPLIN POINT LAB LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Caplin Point Laboratories Ltd?

Answer Field

The share price of Caplin Point Laboratories Ltd for NSE is ₹ 2446.55 and for BSE is ₹ 2429.8.

What is the Market Cap of Caplin Point Laboratories Ltd?

Answer Field

The market cap of Caplin Point Laboratories Ltd for NSE is ₹ 1,85,79.53 Cr. and for BSE is ₹ 1,84,52.33 Cr. as of now.

What is the 52 Week High and Low of Caplin Point Laboratories Ltd?

Answer Field

The 52 Week High and Low of Caplin Point Laboratories Ltd for NSE is ₹ 2490.00 and ₹ 1222.80 and for BSE is ₹ 2486.65 and ₹ 1221.00.

How to Buy Caplin Point Laboratories Ltd share?

Answer Field

You can trade in Caplin Point Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Caplin Point Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 100.32%.

What is the Current Share Price of Caplin Point Laboratories Ltd?

Answer Field

Caplin Point Laboratories Ltd share price is for NSE ₹ 2446.55 & for BSE ₹ 2429.8 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Caplin Point Laboratories Ltd Share?

Answer Field

The market cap of Caplin Point Laboratories Ltd for NSE ₹ 1,85,79.53 & for BSE ₹ 1,84,52.33 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Caplin Point Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Caplin Point Laboratories Ltd share is 61.24.

What is the PB ratio of Caplin Point Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Caplin Point Laboratories Ltd share is 201.93.

How to Buy Caplin Point Laboratories Ltd Share?

Answer Field

You can trade in Caplin Point Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Caplin Point Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Caplin Point Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Caplin Point Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader